$2.17 Million Worth of Masimo Corporation Stock Held by Envestnet Asset Management

Trending News ☀️

Masimo Corporation ($NASDAQ:MASI) is a medical technology company that develops, manufactures, and markets a range of patient monitoring products. The company’s products include pulse oximeters, capnographs, sensors, and related software. Envestnet Asset Management Inc. holds $2.17 million worth of Masimo Corporation stock.

This represents a significant investment by Envestnet in the company.Masimo’s products are used in a variety of medical settings, including hospitals, clinics, and home care. The company’s products are designed to improve patient care and safety.

Price History

The stock opened on Friday at $137.8 and closed at $141.5, up by 3.2% from the previous closing price of $137.0. The company’s products are used in hospitals, clinics, and home settings worldwide.

VI Analysis

Investors interested in a company with strong fundamentals and long-term potential may want to consider MASIMO CORPORATION. The company has a high health score, indicating that it is capable of safely riding out any crisis. Additionally, MASIMO CORPORATION is strong in growth and profitability, making it a good choice for investors looking for capital appreciation. However, the company is weak in dividend payments, so income-seeking investors may want to look elsewhere.

VI Peers

In the medical device industry, there is intense competition between Masimo Corp and its rivals Elekta AB, Essilorluxottica, and Compumedics Ltd. While all four companies offer innovative products and services, each has its own unique strengths and weaknesses. As a result, the competition between them is fierce, and it is often difficult for one company to gain a significant advantage over the others.

– Elekta AB ($OTCPK:EKTAY)

Despite a challenging year for the company, Elekta’s market cap has grown to 2.09B as of 2022. This is due in part to the company’s strong return on equity, which stands at 11.86%. Elekta is a leading provider of radiation therapy solutions for the treatment of cancer. The company’s products are used in over 6,000 hospitals and clinics around the world, and its solutions are backed by a team of over 3,000 employees.

– Essilorluxottica ($LTS:0OMK)

EssilorLuxottica is a French-Italian multinational corporation that designs, manufactures, and markets ophthalmic lenses, instruments, and equipment. The company has a presence in over 130 countries and employs more than 140,000 people. The company was formed in 2018 through the merger of Essilor International and Luxottica.

– Compumedics Ltd ($ASX:CMP)

Computedics Ltd is a technology company that provides computing and analytics solutions. The company has a market cap of 42.52M as of 2022 and a Return on Equity of 1.53%. Computedics Ltd provides computing and analytics solutions to businesses and organizations worldwide. The company offers a range of services, including data storage, cloud computing, data analysis, and security. Computedics Ltd is headquartered in Sydney, Australia.

Summary

Masimo Corporation is a medical technology company that develops and manufactures medical devices. The company’s products are used in a variety of settings, including hospitals, clinics, and home healthcare. Masimo’s products are designed to improve patient care and outcomes. The company’s flagship product, the Rainbow Pulse Oximeter, is used to measure a patient’s oxygen saturation levels.

Masimo’s other products include pulse oximeters, heart rate monitors, and blood pressure monitors. The company has a market capitalization of over $4 billion. Investors interested in buying shares of Masimo Corporation can do so through a broker or online trading platform.